We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, EMA to Hold ‘One-on-One’ Talks on Orphan Drugs With Industry
FDA, EMA to Hold ‘One-on-One’ Talks on Orphan Drugs With Industry
August 20, 2013
The FDA and the European Medicines Agency (EMA) will hold a joint workshop this fall for drug- and devicemakers of orphan products to discuss both agencies’ rare disease programs.